CROs/Service Providers

Charles River Laboratories acquires Celsis International

Wednesday, July 29, 2015 11:40 AM

Celsis International, a global supplier of rapid microbial detection systems, has been acquired by Charles River Laboratories International, a Wilmington, Mass.-based CRO, for $212 million in cash. 

More... »


Avista Pharma Solutions acquires contract services business from Scynexis

Friday, July 24, 2015 09:13 AM

Avista Pharma Solutions has acquired the GMP contract manufacturing, development and animal health services business of Scynexis. Avista will occupy Scynexis’ former research and GMP manufacturing facility in Durham, N.C., and hire substantially all employees associated with the contract services business.

More... »


Parexel updates Perceptive MyTrials Platform

Friday, July 24, 2015 08:34 AM

Global CRO Parexel International launched the next generation of its Perceptive MyTrials platform with advanced analytics capabilities. With the Perceptive MyTrials Analytics solution, clinical trial sponsors now can use a mobile-enabled, single entry-point to access predictive data analytics for multiple studies simultaneously. The solution offers real-time and aggregated analytics allowing sponsors and Parexel clinical research professionals to detect key signals and trends. The Perceptive MyTrials Analytics solution also offers cross-sponsor viewing options for clients who need to evaluate data from multiple sponsors.

More... »

EAG acquires ABC Laboratories

Friday, July 24, 2015 08:32 AM

Evans Analytical Group (EAG), a fully integrated, independent laboratory network based in Boston, has acquired Analytical Bio-Chemistry Laboratories, of Columbia, Mo. (ABC Laboratories). EAG is a private company, majority owned by Odyssey Investment Partners.  Financial terms of the transaction have not been disclosed.

More... »

Covance opens fit-for-purpose Dallas clinical research unit, to add 45 jobs

Friday, July 24, 2015 08:31 AM

Covance Drug Development has relocated its clinical research unit (CRU) in Dallas to a new, fit-for-purpose clinical research facility. The new unit, which opened earlier this month, has expanded from 72 to 100 medical beds and is located in the same building as the prior unit. In addition, a LabCorp patient service center will be co-located in the CRU, at which patients will have an opportunity to learn more about volunteering and participating in early-stage clinical trials.

More... »

PRA Health Sciences launches new initiative to bolster workforce

Friday, July 24, 2015 08:30 AM

Global CRO PRA Health Sciences is looking to hire new talent and is launching a new Candidate Experience initiative.

More... »

AMRI acquires Gadea Pharmaceutical Group

Wednesday, July 22, 2015 01:57 PM

Albany Molecular Research (AMRI), a global contract research and manufacturing organization based in Albany, N.Y., has acquired all the outstanding shares of Gadea Pharmaceutical Group, a privately held company located in Valladolid, Spain, specializing in technically complex active pharmaceutical ingredients (APIs) and finished drug product. The purchase price was $174 million, including the issuance of 2.2 million shares of common stock to Gadea's owners, valued at $43.8 million, with the balance paid in cash and through the assumption of existing debt.

More... »

Epic Sciences, LabCorp expand partnership in Asia

Wednesday, July 22, 2015 01:37 PM

Epic Sciences, a San Diego, Calif.-based developer of novel diagnostics to personalize and advance the treatment and management of cancer, has inked an agreement with Laboratory Corporation of America Holdings (LabCorp), a Burlington, N.C.-based healthcare diagnostics company, to provide circulating tumor cell (CTC) technology and support oncology clinical trials in Asia through Covance Drug Development.

More... »

Frontage Laboratories acquires BDM Consulting

Wednesday, July 22, 2015 01:35 PM

Frontage Laboratories, a full-service CRO based in Andover, Mass., has acquired BDM Consulting, of Summerset, N.J. The acquisition expands Frontage's current capabilities and strengthens its full-service drug and medical device development services across both North America and Asia.

More... »

Almac Group adds regional headquarters, trial supply facility in Singapore

Wednesday, July 22, 2015 01:34 PM

Almac Group, a global contract development and manufacturing organization, has successfully completed the Health Sciences Authority (HSA) inspection of their new Asia Pacific headquarters in Singapore.

More... »

CWWeekly

July 27

AB Science warned about putting study volunteers in danger

FDA, Google unite to detect search-data adverse events

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

Integrated research partnerships build momentum
Research function provides infrastructure, leverages large pool of health systems' patients and data

'Right to Try' laws challenge clinical trial process
20 states pass, 20 more pending allowing access to study drugs without FDA and IRB approval

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

TransCelerate Biopharma turns three
High-profile consortium has made inroads fixing wasteful practices, but it still has more work ahead

Pharma industry improves its tarnished reputation
Delivering innovation, social responsibility will help rebuild trust

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs